0000899243-22-035317.txt : 20221107
0000899243-22-035317.hdr.sgml : 20221107
20221107202950
ACCESSION NUMBER: 0000899243-22-035317
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221101
FILED AS OF DATE: 20221107
DATE AS OF CHANGE: 20221107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HIGGINS JOHN L
CENTRAL INDEX KEY: 0001208906
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33093
FILM NUMBER: 221366924
MAIL ADDRESS:
STREET 1: 11119 NORTH TORREY PINES ROAD, SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000886163
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770160744
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-550-7500
MAIL ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2022-11-01
2022-11-03
0
0000886163
LIGAND PHARMACEUTICALS INC
LGND
0001208906
HIGGINS JOHN L
3911 SORRENTO VALLEY BOULEVARD,
SUITE 110
SAN DIEGO
CA
92121
1
1
0
0
Chief Executive Officer
Common Stock
426731
D
The Form 4 filed on November 3, 2022 inadvertently understated the amount of shares beneficially held in column 5 by 2,000 shares. The number reported herein is correct.
/s/ Andrew Reardon, Attorney-in-Fact for John L. Higgins
2022-11-07